CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cydan Development, Inc., an orphan drug accelerator that identifies and de-risks programs with significant therapeutic potential, today announced that it has selected Cogentis Therapeutics, HIVE Biosystems, LaunchPad Medical, Real Food Solutions and ReThink Pharmaceuticals to receive the Cydan Scholarships for Rare Diseases, Biotechnology & Therapeutics in partnership with MassChallenge.
Help employers find you! Check out all the jobs and post your resume.
